Outgoing Indivior CLO Gets $1.1M In Supernus Merger
Indivior Pharmaceuticals Inc.'s outgoing legal chief will receive about $1.1 million plus health benefits and outstanding awards as he leaves the company following the completion of its merger with Supernus Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article